Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain

被引:14
作者
Bundgaard, H
Havndrup, O
Andersen, PS
Larsen, LA
Brandt, NJ
Vuust, J
Kjeldsen, K
Christiansen, M
机构
[1] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen S, Denmark
[2] Univ Copenhagen, Rigshosp, Ctr Heart, Dept Med B2141, Copenhagen, Denmark
关键词
hypertrophic cardiomyopathy; sudden cardiac death; mutation detection; PCR-SSCP; myosin structure and function; ATP binding;
D O I
10.1006/jmcc.1998.0911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the cardiac beta-myosin heavy chain gene (MYH7), and other genes encoding cardiac sarcomere proteins may cause familial hypertrophic cardiomyopathy (F-HCM), an autosomal dominant disease, characterized by myocardial hypertrophy. We analysed the MYH7 gene in three generations of a family with one borderline and four clinically verified cases of hypertrophic cardiomyopathy, and identified a mutation in exon 7 changing the 190 arginine residue into a threonine residue. The mutation is located in the ATP-binding region of the myosin head and alters the charge in the F-helix close to the phosphate-binding P-loop. The mutation may thus interfere with the coupling between ATP-hyrolysis and the transition into mechanical energy. In conclusion, the novel Arg190Thr mutation in exon 7 of the MYH7 gene is associated with the development of symptomatic myocardial hypertrophy in adults. (C) 1999 Academic Press.
引用
收藏
页码:745 / 750
页数:6
相关论文
共 34 条
[1]  
ALMAHDAWI S, 1994, BRIT HEART J, V72, P105
[2]   Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: An ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly [J].
Becker, KD ;
Gottshall, KR ;
Hickey, R ;
Perriard, JC ;
Chien, KR .
JOURNAL OF CELL BIOLOGY, 1997, 137 (01) :131-140
[3]   CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
BONNE, G ;
CARRIER, L ;
BERCOVICI, J ;
CRUAUD, C ;
RICHARD, P ;
HAINQUE, B ;
GAUTEL, M ;
LABEIT, S ;
JAMES, M ;
BECKMANN, J ;
WEISSENBACH, J ;
VOSBERG, HP ;
FISZMAN, M ;
KOMAJDA, M ;
SCHWARTZ, K .
NATURE GENETICS, 1995, 11 (04) :438-440
[4]  
Charron P, 1997, CIRCULATION, V96, P214
[5]  
Charron P, 1997, GENET COUNSEL, V8, P107
[6]   The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy [J].
Cuda, G ;
Fananapazir, L ;
Epstein, ND ;
Sellers, JR .
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1997, 18 (03) :275-283
[7]  
Dimitrow P P, 1997, J Cardiovasc Risk, V4, P33
[8]   IDENTIFICATION OF A MUTATION NEAR A FUNCTIONAL SITE OF THE BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE IN A FAMILY WITH HYPERTROPHIC CARDIOMYOPATHY [J].
DUFOUR, C ;
DAUSSE, E ;
FETLER, L ;
DUBOURG, O ;
BOUHOUR, JB ;
VOSBERG, HP ;
GUICHENEY, P ;
KOMAJDA, M ;
SCHWARTZ, K .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (09) :1241-1247
[9]   MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY [J].
FANANAPAZIR, L ;
DALAKAS, MC ;
CYRAN, F ;
COHN, G ;
EPSTEIN, ND .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3993-3997
[10]  
HAGEGE A, 1997, CIRCULATION S, V94, pI501